Senescent‑cell‑derived extracellular vesicles tether SASP factors to create tissue‑specific transcriptional halos

Hypothesis

Senescent cells release extracellular vesicles (EVs) that carry heparan sulfate proteoglycans (HSPGs) and act as immobile scaffolds for SASP factors, creating stable, tissue‑specific transcriptional halos that can be resolved by high‑resolution spatial transcriptomics.

Mechanistic rationale

• Senescent cells are rare (<0.5% of tissue) yet exert disproportionate influence via the SASP. Current spatial transcriptomics platforms detect senescent cells only when they form clusters or when bulk signals overwhelm noise, leaving the quantitative shape of SASP gradients unmapped (Spatial mapping of cellular senescence).
• Heparan sulfate chains on cell‑surface HSPGs are known to bind chemokines, growth factors, and cytokines, restricting their diffusion and establishing pericellular niches in development and inflammation. Senescent cells up‑regulate enzymes involved in HSPG biosynthesis (e.g., EXT1, EXTL3) and shed HSPG‑rich EVs, a process that has been observed in cancer‑associated senescence but not quantified in aged tissues.
• If senescent‑cell‑derived EVs deposit HSPG cargo onto the extracellular matrix, they create immobile binding sites that locally concentrate SASP molecules. This reaction‑diffusion system would produce a steep, exponential decay of SASP transcript density with distance, the slope of which would vary according to tissue‑specific HSPG sulfation patterns and EV release rates.

Testable predictions

1. Quantitative halo detection – Using Slide‑seqV2 (10 µm) or HDST (2 µm) on senescent mouse liver and brain, the density of canonical SASP transcripts (e.g., Il6, Cxcl1, MMPs) will follow a measurable exponential decay from CDKN2A‑positive cells, with a characteristic length constant (λ) that differs between liver (λ ≈ 15 µm) and brain (λ ≈ 8 µm) (Advancing biological understanding of cellular senescence).
2. EV‑HSPG dependence – Pharmacological inhibition of neutral sphingomyelinase (GW4869) to block EV release, or siRNA knock‑down of EXT1 in senescent cells, will flatten the SASP gradient (increase λ by >50 %) without altering total SASP mRNA production per cell, as measured by single‑cell RNA‑seq of FACS‑sorted senescent cells.
3. HSPG staining correlation – Immunofluorescence for heparan sulfate (HS) will show puncta colocalizing with senescent‑cell markers; the intensity of HS signal will predict the local SASP transcript density in a linear regression across tissue sections (R² > 0.6).

Falsifiability

If high‑resolution spatial transcriptomics fails to reveal a statistically significant distance‑dependent decay of SASP transcripts around isolated senescent cells, or if manipulation of EV/HSPG pathways does not alter the gradient shape while leaving SASP expression per cell unchanged, the hypothesis would be refuted. Conversely, confirmation would position senescent‑cell‑derived EVs as a fundamental architectural component of the aged tissue microenvironment, explaining how rare senescent cells exert outsized spatial influence.

Experimental workflow (brief)

1. Induce senescence in vivo (e.g., doxorubicin‑treated mouse liver, irradiation‑induced brain senescence).
2. Perform HDST (2 µm) or seqFISH+ panels covering SASP genes, CDKN2A, and EV markers (CD63, CD81).
3. Quantify transcript counts per spot, compute radial averages around each CDKN2A⁺ spot, fit exponential decay.
4. Parallel cohorts receive GW4869 or EXT1 knockdown via AAV; repeat spatial transcriptomics.
5. Conduct HS immunostaining on adjacent sections and correlate with spatial transcriptomic densities.

By integrating quantitative spatial transcriptomics with EV‑HSPG perturbation, this hypothesis directly addresses the current gap in SASP gradient measurements and offers a mechanistic explanation for tissue‑specific senescence effects observed across the SenNet reference tissues (Advancing biological understanding of cellular senescence).